December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Cell Therapy: Visual Performance Is Associated With NTC-200 Mediated Photoreceptor Rescue In The RCS Rat
Author Affiliations & Notes
  • M Neuner-Jehle
    Neurotech SA Evry France
  • PJ Coffey
    Department of Psychology University of Sheffield Sheffield United Kingdom
  • E Clérin
    Neurotech SA Evry France
  • A Darmon
    Neurotech SA Evry France
  • S Brimicombe-Lefevre
    Neurotech SA Evry France
  • A Zerbib
    Neurotech SA Evry France
  • L Hetherington
    Department of Psychology University of Sheffield Sheffield United Kingdom
  • L Vignais
    Neurotech SA Evry France
  • S Timsit
    Neurotech SA Evry France
  • J Crouzet
    Neurotech SA Evry France
  • Footnotes
    Commercial Relationships    M. Neuner-Jehle, Neurotech S.A. E; P.J. Coffey, Neurotech S.A. F; E. Clérin, Neurotech S.A. E; A. Darmon, Neurotech S.A. E; S. Brimicombe-Lefevre, Neurotech S.A. E; A. Zerbib, Neurotech S.A. E; L. Hetherington, Neurotech S.A. F; L. Vignais, Neurotech S.A. E; S. Timsit, Neurotech S.A. E; J. Crouzet, Neurotech S.A. E.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3491. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M Neuner-Jehle, PJ Coffey, E Clérin, A Darmon, S Brimicombe-Lefevre, A Zerbib, L Hetherington, L Vignais, S Timsit, J Crouzet; Cell Therapy: Visual Performance Is Associated With NTC-200 Mediated Photoreceptor Rescue In The RCS Rat . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3491.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Neurotech S.A. is developing cell-based therapies for the treatment of ophthalmic disorders with a special interest in retinal degeneration. One of the Company's strategies consists of transplanting well-characterized viable human retinal pigment epithelium (RPE) cells into the subretinal space in order to replace dysfunctional endogenous RPE cells. The proof of efficacy of this approach has been demonstrated recently in the Royal College of Surgeons (RCS) rat modela. In the present study, we examined whether or not the immortalized human RPE cell line NTC-200 could rescue photoreceptors when injected into the subretinal space of dystrophic RCS rats. In addition, the visual performance of the treated rats was assessed. Methods: Three-week-old pigmented dystrophic RCS rats were treated under general anesthesia by a unilateral injection of 2x105 cultured NTC-200 cells (2 µl) into the temporal superior subretinal space using a trans-scleral approachb. Sham-treated dystrophic RCS rats received a unilateral subretinal injection of 2 µl graft medium. All rats remained under cyclosporin regimen throughout the test period. At the age of 12 weeks, all rats were subjected to optokinetic reflex testings using the spatial grating frequency of 0.5 cycles/degreec. Subsequently, the rats were sacrificed for histology and photoreceptor nuclei counting. Results: The presented behavioral and anatomical data reveal an association between the response to the presented grating stimulus and the photoreceptor rescue. These results confirm anatomical and functional data obtained earlier with other cell linesa or factorsd. Conclusion: NTC-200-mediated delay or slowing of the deterioration of the rats' visual performance is associated with photoreceptor rescue. a Lund et al. (2001) Proc. Natl. Acad. Sci. USA 98(17):9942-9947, Coffey et al. (2001) Nat. Neurosci., in press. b All animal experiment procedures conform to NIH guidelines. c Cowey & Franzini (1979) Exp. Brain Res. 35:443-455. d Whiteley et al. (2001) ARVO poster #3392.

Keywords: 607 transplantation • 567 retinal pigment epithelium • 308 age-related macular degeneration 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.